Who
Michael Andrew Holloway
Director
Company insider
Files Form 4 as: Director, Lixte Biotechnology Holdings.
In numbers
- Trades disclosed
- 7
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Aug 2025
- Last trade
- 1 Jul 2026
- Last filed
- 2 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Jul 2026filed 2 Jul 2026 | Lixte Biotechnology HoldingsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 1 Jul 2026filed 2 Jul 2026 | NMAD Nomad Power SolutionsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 15 Apr 2026filed 17 Apr 2026 | Lixte Biotechnology HoldingsBiotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 15 Apr 2026filed 17 Apr 2026 | Lixte Biotechnology Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code D | —25,000 | filing |
| 15 Apr 2026filed 17 Apr 2026 | NMAD Nomad Power Solutionsoption or derivative · Biotechnology | SEC FORM 4 Code D | —25,000 | filing |
| 15 Apr 2026filed 17 Apr 2026 | NMAD Nomad Power SolutionsBiotechnology | SEC FORM 4 Code A | —25,000 | filing |
| 15 Aug 2025filed 18 Aug 2025 | NMAD Nomad Power Solutionsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.